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Although the accumulation of glomerular basement membrane (GBM) 1 and base- 
ment membrane-like material in human diabetes is well documented (1-4), evidence 
supporting  the  occurrence of similar changes  in  animal  models with  experimental 
diabetes  is  not  uniformly  accepted.  Several  investigators  have  observed  increased 
glomerular basement membrane thickness in monkeys (5) and rats (6, 7) with chronic 
alloxan  diabetes  and  in  rats  with  long-term streptozotocin  diabetes  (8),  but  other 
workers have been unable to find pathologic alterations in glomeruli from experimen- 
tally diabetic rats  (9,  10).  Similarly, changes in parameters of basement membrane 
synthesis in glomeruli  from diabetic animals have been found in some, but  not all, 
studies. For example, Wahl et al. (11) could not demonstrate increased incorporation 
of labeled  glucose  into  GBM  when  glomeruli  from aUoxan  diabetic  animals  were 
compared with  those  from nondiabetic  animals.  Beisswenger  (9)  reported  that  the 
incorporation  of 14C-lysine and appearance of hydroxy-14C-lysine in  GBM of incu- 
bated glomeruli from streptozotocin-diabetic rats was not significantly different from 
that  of nondiabetic  glomeruli.  Other investigators, on  the  other hand,  have found 
increased  14C-hydroxyproline  (12)  and  14C-hydroxylysine  (13)  synthesis  in  isolated 
glomeruli from diabetic rats, as well as an increase in the activities of the glomerular 
lysyl hydroxylase (14,  15) and renal glucosyltransferase (16)  enzyme systems, both of 
which are intimately involved in GBM biosynthesis. 
As  part  of a  series  of experiments  examining  basement  membrane  synthesis  in 
glomeruli isolated from normal and streptozotocin-diabetic rats, we have been able to 
accurately  assess  glomerular  size  and  basement  membrane  content  in  glomeruli 
obtained from >200  such  animals.  The findings presented  below demonstrate that 
glomeruli  from streptozotocin-diabetic  rats  are  larger and  contain  more basement 
membrane than do non-diabetic glomeruli. 
Materials and Methods 
Experimental Animals  and  Tissue Preparation.  Kidneys were obtained  from male white rats 
immediately after sacrifice by anesthetic overdose or by placement in a carbon dioxide chamber, 
and the renal cortex was separated by gross dissection.  Diabetic animals were sacrificed  35-45 
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d  after  tail vein injection of streptozotoein, 85  mg/kg of body weight.  Streptozotocin was 
administered when the rats weighed between 80 and 120 g, and noninjected litter mates served 
as  controls.  The  renal  cortical  tissue  from  normal  and  diabetic  animals was  pooled  for 
glomerular  isolation;  cortices  from  9  to  34  animals  per  group  were  employed  for  each 
experiment. 
Glomeruli were isolated essentially as described by Spiro (17), sequentially using stainless- 
steel meshes of the following pore sizes: 149, 250, and finally, 63 #m. A wash solution of cold 
buffered saline (0.85% NaC1) was employed. With this process, connective tissue and tubular 
fragments are retained by the first two sieves, whereas glomeruli are retained by the final sieve. 
The preparation is routinely almost completely devoid of tubular elements and consists  of 
glomeruli >63 #m but <149/~m in diameter, which has been repeatedly confirmed by direct 
microscopic measurement. Using a  Pasteur pipette  and  small amounts of buffered saline, 
glomeruli are collected from the final sieve by repeated rinsing and aspiration, followed  by 
centrifugation at 1,000 rpm for 10 min, and suspension of the glomerular pellet in cold buffered 
saline. Glomerular yield was determined by counting the number of glomeruli in three separate 
0.002-ml samples of each preparation under the light microscope at  × 100 power.  Glomerular 
preparations were well agitated immediately before removal of each aliquot to assure uniform 
suspension, and the  total  number of glomeruli in the  preparation was  calculated from an 
average of the three samples counted. Material retained by the first two sieves (149 and 250 
pm), as well as a sedimented concentrate of the wash through the final sieve were routinely 
examined after suspension in buffered saline. The 250-/~m retentate contains only larger tissue 
fragments, whereas  the  149-pm  retentate is comprised of tubular elements with occasional 
embedded glomeruli. Glomeruli isolated by this procedure were intact and discrete,  with sharp 
borders and microscopically visible refractile cellular elements. These preparations actively 
incorporate label into protein and collagen when incubated in vitro (18). 
Sample Analysis.  Glomeruli were suspended in  10-50 ml  (depending on total number of 
glomeruli in the preparation) of cold buffered saline containing proteolytic inhibitors (19) and 
disrupted in 10-20-ml aliquots with a sonicator providing about 300 W of energy (Biosonik IV, 
Braun Co.,  San Marco, Calif.) by 1-min bursts for a total of 10 min. The preparations were 
monitored light microscopically for completeness of disruption, which was typically >90% in 
normal samples.  When disruption was judged incomplete, ultrasound treatment was repeated 
for 5 min with l-min bursts, and the preparation re-examined. Glomeruli from diabetic animals 
sometime  required  at  least  one  such  additional  5-rain  period  of sonic  disruption.  Paired 
experiments with normal and diabetic giomeruli showed  that extension of the sonication time, 
as  reported  by Spiro  (20),  did not  lead  to any change in the composition of the basement 
membranes, but did result in more complete collection of GBM in diabetic samples. Adequate 
disruption was important to ensure quantitative collection of basement membranes because the 
membranes of undisrupted diabetic glomeruli could not be recovered for subsequent analysis. 
The basement membranes were  then rapidly collected by low-speed  centrifugation (1,200 g); 
centrifugation time was kept short (1-2 rain) to avoid contamination  with intracellular  elements 
and the supernate was removed with great care. In earlier experiments (Table I, normal animal 
groups 1-3 and diabetic animal groups 8-9), the membranes were washed several times with 
0.1 M acetic acid at 4°C, whereas in the remainder of the experiments membranes were washed 
three times with a solution of 1 M  NaCI, 0.05 M Tris containing protease inhibitors (19). Use 
of the latter solution was  initiated to minimize endogenous proteolytic activity which could 
artifactually alter the relative solubility of the membrane proteins. Washing with one of these 
solutions is essential to remove contaminating intracellular proteins and adherent interstitial 
collagen but the chemical identity of normal and diabetic glomerular basement membrane 
prepared after treatment with either of these solutions is the same. Because glomerular basement 
membrane is insoluble in dilute acetic acid or salt, this process  allows for  its  isolation as  a 
gelatinous residue which  is  relatively pure  when  subjected to  amino acid  analysis (13). A 
differential effect  of either washing procedure on normal and diabetic basement membrane 
was not observed. The supernate from either of these washes is devoid of 3-hydroxyproline and 
hydroxylysine and contains none of the  characteristic absorption peaks  of rat  GBM  when 
analyzed by gel chromatography after reduction and denaturation.  2 
Some peptide-bound hydroxy-14C-lysine  is found in the acetic acid extract of basement membrane 
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Aliquots of the glomerular basement  membrane preparations  were assayed for protein by an 
adaptation of the method of Lowry in which the protein was solubilized with  1 N NaOH for 
30 rain  at room temperature.  Relative  color yields with  the Lowry technique  of normal and 
diabetic  glomerular  basement  membrane,  determined  by  absorption  curves  on  identical 
amounts of lyophilized  material,  were the same. The remainder of the samples was reduced 
and denatured by heating at  100*C for 2 min in 2 ml of 1% (wt/vol)  sodium dodecyl sulfate 
(SDS)  and  5%  (vol/vol)  2-mereaptoethanol  in  0.1  M  sodium  phosphate  buffer  (pH  7.4). 
Samples were then incubated for 2 h at 37°C and dialyzed  at room temperature against  two 
changes  of 500 ml of 0.1% SDS in 0.1  M  sodium  phosphate buffer  (pH  7.4). Unsolubilized 
material  was removed by centrifugation  at 3,000 g for 10 min. Comparable amounts (by protein 
determination)  of normal  and diabetic  preparations  were chromatographed at room tempera- 
ture on a 1.5  ×  95-cm column of 6% agarose (Biogel, Bio-Rad Laboratories,  Richmond, Calif. 
A-5m; 200-400 mesh) which was equilibrated  and eluted with 0.1 M sodium phosphate buffer 
containing 0.1% SDS. Void volume was determined  with blue dextran,  and the column was 
calibrated  with the following protein  standards:  3H-procollagen prepared from chick embryo 
caivaria  (21), collagen a-chains  prepared  from  lathyritie  rat  sternal  cartilage,  bovine  serum 
albumin,  and trypsin.  Effluent  fractions  were monitored spectrophotometrically  for UV ab- 
sorption at 230 nm. 
Results 
Pertinent data concerning the experimental animal groups are presented in Table 
I.  Streptozotocin-diabetic rats were markedly hyperglycemic and exhibited  stunted 
growth at the time of sacrifice ~6 wk after injection. Individual values for the amount 
of renal  cortex and basement  membrane protein,  and  for the number of glomeruli 
obtained in each animal group, are also given in Table I. 
The number of glomeruli obtained with the differential sieving technique employed 
directly reflects that proportion of all glomeruli with a diameter between the 63- and 
149-/~m limits of the sieving system. Experiments in our own and other (22)  labora- 
tories have established that glomerular size is related to body weight, with the mean 
glomerular  diameter  (determined  by micrometry)  proportional  to  body weight  in 
animals 75-300 g. It is therefore necessary to consider the weight of the animals when 
comparing glomerular or basement membrane yields between nondiabetic and dia- 
betic rats.  As seen in Fig.  1 A, glomerular yields  (number of glomeruli per gram of 
renal cortex per gram of body weight) were significantly greater in diabetic prepara- 
tions. Although this finding could in part represent a decrease in the nonglomerular 
mass of diabetic rats, it is also consistent with an increased mean glomerular diameter 
in diabetic kidneys. This interpretation was confirmed by optical estimates in which 
the  first  20 glomeruli in each sample were measured with a  micrometer (N  =  118 
±  6/~;Db  =  132  ±  8/~). 
The  yield  of basement  membrane,  expressed  either  as  micrograms of basement 
membrane protein per gram of renal cortex (N  =  27.83  +  5.76; Db  =  55.62  ±  9.92; 
P  <  0.05)  or as  10  -s g of basement membrane protein per gram of renal cortex per 
gram of body weight was also significantly greater in diabetic preparations (Fig.  1 B). 
Calculation of the amount of basement membrane protein per glomerulus (Fig.  1 C) 
demonstrated that this finding actually represented glomerular basement membrane 
accumulation rather than the  (unlikely)  possibility that diabetic samples have more 
glomeruli. The amount of basement membrane was greatest in animal groups with 
which represents newly synthesized basement membrane collagen-like protein produced in vitro, appears 
to have different solubility characteristics from mature basement membrane which, as demonstrated by 
several investigators, is insoluble in acetic acid (23). 626  GLOMERULOPATHY IN STREPTOZOTOCIN DIABETES 
TABLE I 
Experimental Animal Data 
Num-  Basement 
Animal  ber an-  Body wt  Blood glu-  Cortex  No. glomeruli  membrane 
group  imals  cose  (protein) 
g  raM~liter  g  X  I0  "~'  gg 
I Normal  10  383  <8.0  19.2  3.060  450 
2 Normal  10  380  <8.0  18.4  2.816  627 
3 Normal  18  300  <8.0  30.5  4.500  650 
4 Normal  27  407  <8.0  78.5  14.920  728 
5 Normal  24  366  <8.0  52.3  37.600  2,204 
6 Normal  30  230  <8.0  57.0  10.800  770 
7 Normal  34  370  <8.0  52.9  16.800  2,700 
Mean  -  SEM  348  ±  23  <8.0  44.1  +  8.4  12.928 ±  4.636  1,161  ±  340 
8 Diabetic  i0  211  21.89  22.6  4.258  880 
9 Diabetic  9  203  22.00  22.8  4.648  1,040 
10 Diabetic  17  273  23.44  52.3  25.100  1,872 
11  Diabetic  18  249  22.28  32.9  26.400  2,355 
12 Diabetic  26  243  25.39  32. l  12.700  2,770 
Mean  :lz  SEM  236  ±  13"  23.0  ±  .66*  32.5  ±  5.4  14.621 ±  4.791  1,783 ±  365 
Body weights and blood glucose values recorded are the averages for each group. * P <  0.01 compared to 
nondiabetic values. 
the longest duration of diabetes (Table I, groups 10 and 11), but statistical correlation 
could not be made with the available data. 
About 65% of both normal and diabetic basement membrane protein was solubi- 
lized  by  reduction  and  denaturation  in  the  presence  of SDS.  This  finding  is  in 
agreement with other studies on the solubility of nondiabetic glomerular basement 
membrane (23).  Hydroxylysine (24) and hydroxyproline (25) assay of the solubilized 
material was performed to determine if this procedure resulted in the solubilization 
of similar polypeptide components in normal and diabetic samples. Molecular sieve 
chromatography of the reduced and denatured basement membrane revealed several 
major absorbance peaks, including one at the void volume. Elution profiles of normal 
and  diabetic  samples  were  similar,  with  neither  the  presence  nor  absence  of any 
specific peak noted in the diabetic preparations  (Fig.  2).  Reference to a  calibration 
curve indicated that these components had apparent molecular weights ranging from 
~30,000 to >300,000 daltons. 
Discussion 
The role of genetic versus environmental factors in  the  pathogenesis of diabetic 
nephropathy and  in  relation  to capillary basement  membrane thickening remains 
controversial. Although many authorities believe that the presence of chronic hyper- 
glycemia critically contributes to the putative processes which  lead  to microangio- 
pathic lesions (20,  26), it is difficult to obtain conclusive evidence in support of this 
relationship in human populations. These problems could more easily be approached 
in  animal  models  with  experimental  diabetes  where  investigation  of glomerular N 
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Fro.  1.  Glomerular and basement membrane yields in normal and diabetic rats. 1  A, The number 
of glomeruli recovered per gram of renal cortex relative to the body weight in grams. 1  B, The 
amount  of basement membrane protein obtained per gram of renal cortex relative to the body 
weight in grams. Values reported as  10  -s g of protein.  1  C, The amount of basement membrane 
protein calculated per glomerulus relative to body weight. Values reported as 10  -x2 g of protein. 
Values represent mean  +  SEM of the results obtained with pooled renal cortical tissue in each 
animal group as listed in Table I. * P < 0.05 compared to nondiabetic values. N, nondiabetic; D, 
diabetic. 
pathology and  biochemistry  under controlled  conditions could  define  the  effects of 
nutritional,  hormonal,  and  other  factors  on  glomerular  metabolism  and  basement 
membrane  deposition.  There  is  considerable  reservation,  however,  regarding  the 
occurrence of nephropathic changes in experimental diabetes that correspond to those 
found in  human  diabetes,  and  these reservations  continue to cloud the significance 
and  acceptance of chemical  and biosynthetic  alterations  which have been  found in 
glomeruli from such animals. 
The elegant  studies  of Osterby  and  her  colleagues  have  established  that  human 
diabetic  nephropathy  begins  after  the  onset  of juvenile  diabetes,  with  measurable 
thickening of the peripheral capillary basement membrane occurring by 2 yr after the 
manifestation  of clinical  disease  (4,  27, 28).  The gradual  progression of this  process 
leads to the accumulation of large amounts of basement membrane in the glomerular 
tuft with ultimate  occlusion of the capillary network.  Glomerular enlargement  is an 
associated  change,  occurring  in  part  as  a  result  of the  excess  deposition  of solid 
material  and,  in  part,  due  to  a  compensatory  hypertrophy  of functioning  open 
glomeruli (29-32). Certainly the present study, which documents increased glomerular 
size  and  increased  basement  membrane  in  rats  with  streptozotocin  diabetes,  now 
establishes  that the glomerular expansion and accumulation of basement membrane 
which are characteristic  of human  diabetic  nephropathy occur in this  experimental 
animal  model.  Furthermore,  these changes occur despite  weight  loss and  attendant 
loss of protein and fat in other tissues.  Several studies have shown that renal protein 
synthesis  paradoxically  increases  in  diabetes,  in  contrast  to  the  effect  of insulin 
deficiency in other tissues  (13, 33, 34). It is suggested that this increase contributes to 
the accumulation of glomerular basement membrane in diabetes. Although we cannot 
completely explain  the  difference between  our results  and  those of Beisswenger  (9), 
who reported  that  the yield of glomerular basement  membrane  from streptozotocin 
diabetic  rats  was  not  different  from  that  of normal,  it  is  noted  that  the  basement 
membranes  analyzed  in  that  portion  of the  study  contained  <2%  hydroxylysine, 
suggesting considerable contamination. 
Chemical analyses of glomerular basement  membrane have not provided satisfac- 628  GLOMERULOPATHY  IN STREPTOZOTOCIN  DIABETES 
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Fio.  2.  Gel filtration on SDS-agarose of normal and diabetic rat glomerular basement membrane. 
The basement membranes were purified by treatment with cold 1 M NaC1, 0.05 M Tris-HC1 (pH 
7.5) containing  protease  inhibitors  as  described  in  the text,  and  solubilized by reduction  and 
denaturation  in  the  presence  of SDS. Approximately 500  p.g  (protein)  of this  material was 
chromatographed  on a 1.5  ×  95-cm calibrated column of agarose A-5m. The void volume was at 
fraction  22  and the total volume at fraction  70. Arrows indicate  the elution  positions of chick 
embryo calvaria procollagen prepared according to the method  of Monson et al. (21) and of a- 
chains prepared from lathyrltie rat sternal cartilage. The elution profiles depicted above represent 
the average absorption of four separate runs performed in each of the experimental groups (normal 
animal groups 4-7; diabetic animal groups 10-12). Q, nondiabetic; ©, diabetic. 
tory insight into the problem of diabetic nephropathy.  Glomerular basement  mem- 
brane from diabetic patients has been reported to contain more hydroxylysine residues 
and  hydroxylysine-linked disaccharide units  by  some  (35,  36)  but  not  all  (37,  38) 
investigators. There is now considerable evidence supporting the heterogeneous nature 
of basement  membranes,  which  includes the presence of multiple collagen-like and 
non-collagen components (39-43).  Increased or decreased proportions of one of these 
components  would  not  necessarily alter  the  amino  acid  pattern  of unfractionated 
glomerular basement  membrane  unless  the  composition of these  components  were 
strikingly different from the rest of the basement membrane. This problem cannot be 
resolved  until  the  absolute  amounts  of  all  the  subunits  in  normal  and  diabetic 
glomerular  basement  membrane  are  determined.  Each  of the  peaks  identified  on 
agarose gel analysis of normal and diabetic basement membrane in the present study 
probably contains many components, and it is not surprising that the chromatographic 
patterns were similar. Even if abnormal components were present, dilution of such by 
the still present normal basement membrane with slow turnover might have obscured 
minor differences (20,  44).  This analysis, however,  at  least represents a  step toward 
resolution of the controversy surrounding basement membrane chemistry in diabetes, 
and  meaningful  data  should  evolve  from  further  delineation  of  the  normal  and 
diabetic basement membrane components. Results from our most recent experiments 
support  the concept  that  diabetic glomerular basement  membrane,  although  quan- 
titatively increased, is qualitatively similar to that of normal. 
Evidence  is  accumulating  that  biosynthetic  abnormalities  related  to  glomerular 
basement  membrane  production  can  be  demonstrated  in  experimental  diabetes MARGO P.  COHEN AND CARLYN V.  KLEIN  629 
(12-16). That these changes have pathologic significance is confirmed in the present 
report.  Although  one must  always exercise caution  in  directly applying data  from 
experimental models to human disease, it is concluded that use of the streptozotocin- 
diabetic rat  is suitable for the study of mechanisms and factors contributory to the 
development and progression of diabetic nephropathy. 
Summary 
Glomeruli  from  streptozotocin-diabetic  and  age-matched  nondiabetic  rats  were 
quantitatively isolated by a  differential sieving technique.  The insoluble glomerular 
basement  membranes  were  purified  following  sonic  disruption  in  the  presence  of 
proteolytic inhibitors. The yield of glomeruli and of glomerular basement membrane 
relative to the amount of renal cortex and the body weight of the animals, as well as 
the calculated amount of basement membrane per glomerulus, were all significantly 
greater in diabetic rats when compared to non-diabetic controls. Glomerular basement 
membranes from normal and diabetic rats were solubilized by reduction  and dena- 
turation in the presence of SDS and subjected to agarose gel analysis. About 65% of 
both  normal  and  diabetic  basement  membrane was solubilized  by this  procedure, 
and the elution profiles of non-diabetic and diabetic preparations were similar. These 
results suggest that rat renal basement membrane is qualitatively similar but quan- 
titatively  increased  in  streptozotocin-diabetes.  Since  glomerular  enlargement  and 
accumulation of basement membrane are characteristic of human diabetic nephrop- 
athy, the findings also suggest that the streptozotocin-diabetic rat  is an appropriate 
animal model for studies relating to the pathogenesis of this complication of diabetes. 
The skillful  secretarial assistance  of Ms. Joan Quinones is acknowledged.  Streptozotocin was 
kindly supplied by the Upjohn Company, Kalamazoo, Michigan. 
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